Profound Medical
PROF
52 hedge funds and large institutions have $103M invested in Profound Medical in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 6 closing their positions.
280% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 5
183% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 6
164% more call options, than puts
Call options by funds: $29K | Put options by funds: $11K
37% more capital invested
Capital invested by funds: $75M → $103M (+$28.1M)
18% more funds holding
Funds holding: 44 → 52 (+8)
7.4% more ownership
Funds ownership: 38.47% → 45.86% (+7.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.91M |
| 2 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$3.76M |
| 3 |
ACM
Altium Capital Management
New York
|
+$3.72M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$2M |
| 5 |
FG
Formula Growth
Montreal,
Quebec, Canada
|
+$1.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$427K |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$119K |
| 3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$109K |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$92.5K |
| 5 |
GSEP
Golden State Equity Partners
South Coast Metro,
California
|
-$31.5K |
PROF Hedge Fund Activity: Q4 2024 in Review
52 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2024, worth a combined $103M — up 37% from $75M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PROF positions and 6 closed out — a net gain of 11 holders — while 19 added to existing stakes and 5 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $3.91M. The largest seller was Millennium Management, exiting entirely with an estimated $427K sold.
- 52 institutional investors held Profound Medical (PROF) as of Q4 2024, up from 44 in Q3 2024.
- Funds reported $103M of Profound Medical stock for Q4 2024, up 37% quarter-over-quarter.
- 17 funds opened new Profound Medical positions in Q4 2024 and 6 closed out, a net change of +11 holders.
- The largest Profound Medical buyer in Q4 2024 was Magnetar Financial, an estimated $3.91M added.
- The largest Profound Medical seller in Q4 2024 was Millennium Management, an estimated $427K sold.
Based on aggregated 13F filings for Q4 2024.